SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention after falling to reported record lows, with traders pointing to concerns about Trump Medias losses, dilution, weak Truth Social engagement and Trumps declining approval ahead of the midterms. The discussion is overwhelmingly bearish, though some traders frame the drop as a buying opportunity.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is drawing attention for its prolonged selloff and repeated lows, amid analyst target cuts and concerns about weak roofing and housing demand, elevated rates, and the debt and dilution tied to its acquisition-led expansion. Traders are split between expecting further declines and viewing the depressed valuation as an opportunity if the roll-up strategy delivers integration and margin progress.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns about CoreWeaves debt burden, bond-market stress and ability to finance its AI data-center expansion dominate the discussion, while Goldman Sachs Buy upgrade has fueled hopes for a rebound. Traders remain divided: bulls call the selloff overdone and anticipate a squeeze, while bears say financing risks and weak price action outweigh the upgrade.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs prolonged selloff and sharp underperformance despite Bitcoin holding near elevated levels dominate discussion, with traders blaming weak sentiment and the lack of signed AI/data-center tenant deals. Bearish frustration over management and the unproven pivot competes with dip-buying and speculation that a lease announcement or Bitcoin rebound could lift shares.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is drawing attention for its sharp, volatile moves and its role as an indium phosphide substrate supplier for AI data-center optics. Bulls point to AI-driven demand and recent business momentum, while bears argue the shares are overvalued and flag China-related supply risks; the debate is amplified by heavy trading around earnings and technical levels.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares are surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, addressing the FDAs earlier concerns about clinical benefit after a prior rejection. Traders are debating whether the move has room to extend, including speculation about short covering, versus profit-taking and resistance; FDA approval is still pending, and some raise concerns about dizziness reported in the trial.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunruns push to monetize its residential solar-and-battery network for distributed power and AI computing is a major topic, with traders debating the potential of its pilot and partnerships against the stocks persistent weakness. Bulls also point to heavily short positioning, while bears cite financing and interest-rate sensitivity and broader solar-sector pressure.

Annaly Capital Management, Inc. engages in the investment and financing of residential and commercial assets. It operates through the following segments: Agency, Residential Credit, Mortgage Servicing Rights (MSR), and Corporate and Other. The Agency segment invests in agency mortgage-backed securities. The Residential Credit segment is involved in non-agency residential mortgage assets within securitized products and whole loan markets. The MSR segment provides the right to service residential mortgage loans in exchange for a portion of the interest payments made on the loans. The company was founded by Michael A. J. Farrell and Wellington Jamie Denahan-Norris on November 25, 1996 and is headquartered in New York, NY.

Annaly Capital Management Inc

NLY is drawing attention after sliding to reported 52-week lows alongside other mortgage REITs, with traders tying the weakness to interest-rate and mortgage-bond repricing concerns. Some view the selloff as a chance to buy for the high dividend, while others worry that persistent rate pressure could weigh further on the shares and payout.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Bitcoins volatile swings and the rebound in crypto-linked stocks are driving attention to Coinbase, with traders frequently debating whether COIN is lagging the crypto market. Sentiment is split between optimism ahead of Q3 earnings and skepticism over the stocks sharp reversals and weak relative performance.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanley naming Amazon a top pick, citing AWS growth and AI opportunities, is the main catalyst behind the sharp rally. Traders are broadly upbeat, while some question whether the upgrade-driven move will hold and remain cautious about capex and the upcoming earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RGCs sharp move higher is drawing momentum-trading interest, with traders speculating about a repeat meme-stock or short-squeeze run based on its past spikes and reportedly tight share float. Others warn the move may be a pump-and-dump, citing the companys weak fundamentals and the stocks extreme volatility.

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion.
SenesTech (NASDAQ:SNES) stock rose 24.93% toread more...

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million.
Regencell Bioscience (NASDAQ:RGC) stock moved upwards byread more...

Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm PR Newswire NEW YORK, June...

Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the Class Period). Regencell is a purported...

RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm

RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The...

RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regencell Bioscience Holdings Limited (Regencell or the Company) (NASDAQ: RGC) and reminds investors of the June 23, 2026 deadline to seek the role of lead plaintiff in a federal securities class...

Deadline Soon: Regencell Bioscience Holdings Limited (RGC)Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming June 23, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Regencell Bioscience Holdings Limited (Regencell or the Company) (NASDAQ: RGC...

RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026 RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on...

SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC

SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC PR...

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC PR Newswire NEW YORK, June 18, 2026...

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

RGC Stock Gains 20% Pre-Market — Retail Says Shorts Are In ‘Huge Trouble’

Equity

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Regencell stated in an October SEC filing that it may be required to curtail or discontinue its operations in the future.</li><li>In the 2025 and 2024 fiscal years, Regencell reported a net loss of $3.58 million and $4.36 million, respectively.</li><li>The company had indicated that it anticipates incurring additional losses before realizing any revenues.</li></ul>Shares of Regencell Bioscience Holdings (RGC) have been drawing significant investor attention after gaining nearly 152% in the first four trading sessions of 2026.Following Wednesday’s relentless rally, the shares continued to climb in Thursday’s pre-market trade as well, rising by over 20% at the time of writing.While the bulk of the recent surge has come in 2026, RGC stock is still up nearly 218% since October 31, despite the company flagging a “substantial doubt” about its ability to continue as a going concern.<figure class="image"><img src="https://news.stocktwits-cdn.com/RGC_stock_chart_jpg_b4d92bf445.webp" alt="RGC stock performance from Jan. 1, 2025 to Jan. 7, 2025" width="1516" height="417"><figcaption>RGC stock performance from Jan. 1, 2025 to Jan. 7, 2025 | Koyfin</figcaption></figure><h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits regarding Regencell Bioscience was trending in the ‘bullish’ territory at the time of writing.One bullish user thinks that traders shorting the stock are in “huge trouble now.”<stembedurl>https://stocktwits.com/elbardinnyo/message/641188884</stembedurl>Another user said they treat it as a momentum-only stock.<stembedurl>https://stocktwits.com/Faniabh/message/641180065</stembedurl><h2 class="st-heading-2">RGC’s Going Concern Flag</h2>In a filing with the U.S. Securities and Exchange Commission in October 2025, the company said that there is a “substantial doubt” about its ability to continue as a going concern.It added that this indicates the company may be required to curtail or discontinue its operations in the future.“If we discontinue our operations, you may lose all of your investment,” Regencell said, adding that it anticipates incurring additional losses before realizing any revenues. In the 2025 and 2024 fiscal years, Regencell reported a net loss of $3.58 million and $4.36 million, respectively.Regencell is an early-stage company focusing on research, development, and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder.<a href="https://stocktwits.com/symbol/RGC">RGC stock</a> is up 152% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-hele-stock-falling-today/cmUb4SeR4Po">HELE Stock Slides Pre-market As Tariff Headwinds Trigger FY26 Earnings Guidance Cut</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Regencell shares are up nearly 218% since October 31, despite the company flagging a “substantial doubt” about its ability to continue as a going concern.

Why Is RGC Stock Soaring Today?

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Stocktwits

SpaceX

Netflix Inc

Meta Platforms Inc

Which earnings release are you most looking forward to this week: 

Stocktwits Polls

Traders are betting on a massive short squeeze, citing locked-up shares and low float availability as catalysts for potential parabolic moves.

Discussions are dominated by the stock's unpredictable nature as a China-based play, with constant warnings of rug pulls and investigative headlines.

Enthusiastic traders are actively speculating on near-term gains with aggressive price targets ranging from $15 to $50.

Retail investors are comparing recent price action to past multi-hundred percent runs, labeling it as a classic meme stock contender.

Current Price	$10.17
Prev Close	$9.59
Open	$9.32
Dividend Yield	0.00%
50-Day Moving Average	$6.22
Beta	0.19
Avg. Volume	172,009.01
PE Ratio	-406.36

52-Week High	$69.00
52-Week Low	$4.51
Market Capitalization	$4.76B
EPS (Annual)	-$0.0237
Price to Book	356.24
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

RGC Fundamentals